These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 7868900)

  • 1. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production.
    Shibata Y; Metzger WJ; Myrvik QN
    J Immunol; 1997 Sep; 159(5):2462-7. PubMed ID: 9278339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
    J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the interrelationship between IL-12, TNF-alpha, and IFN-gamma production during murine listeriosis.
    Liu W; Kurlander RJ
    Cell Immunol; 1995 Jul; 163(2):260-7. PubMed ID: 7606797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
    Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
    J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.
    Marfaing-Koka A; Devergne O; Gorgone G; Portier A; Schall TJ; Galanaud P; Emilie D
    J Immunol; 1995 Feb; 154(4):1870-8. PubMed ID: 7530744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study.
    Carpenter EA; Ruby J; Ramshaw IA
    J Immunol; 1994 Mar; 152(6):2652-9. PubMed ID: 8144873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
    Ferran C; Dautry F; Mérite S; Sheehan K; Schreiber R; Grau G; Bach JF; Chatenoud L
    J Clin Invest; 1994 May; 93(5):2189-96. PubMed ID: 8182150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.
    Zou JP; Shimizu J; Ikegame K; Yamamoto N; Ono S; Fujiwara H; Hamaoka T
    J Immunol; 1992 Jan; 148(2):648-55. PubMed ID: 1345922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch.
    Lee H; Baek S; Joe SJ; Pyo SN
    Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen presentation by individual clones of mouse splenic macrophages. Selective expression of IL-1 alpha in response to CD8+ T cell-derived IFN-gamma defines the alloantigen-presenting phenotype.
    McCormack JM; Askew D; Walker WS
    J Immunol; 1993 Nov; 151(10):5218-27. PubMed ID: 8228220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.